E A H Loeffen1, A Brinksma, K G E Miedema, G H de Bock, W J E Tissing. 1. Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.
Abstract
PURPOSE: In childhood cancer patients, malnutrition has been proposed to increase infection rates and reduce survival. We investigated whether malnutrition at diagnosis and during treatment and weight loss during treatment are prognostic factors for infection rates and survival, within a heterogeneous childhood cancer population. METHODS: From two previous studies, all children ≤18 years of age diagnosed with cancer between October 2004 and October 2011 were included in this study. Data regarding BMI, infections, and survival were retrieved. Patients with a BMI z-score lower than -2.0 were classified as malnourished. Weight loss more than 5% was considered relevant. RESULTS: Two hundred sixty-nine childhood cancer patients were included in this study. At diagnosis, 5.2% of all patients were malnourished. These patients showed worse survival than those who were well nourished (hazard ratio (HR) = 3.63, 95% confidence interval (CI) = 1.52-8.70, p = 0.004). Malnourishment at 3 months after diagnosis (3.3% of all patients) also showed worse survival (HR = 6.34, 95% CI = 2.42-16.65, p < 0.001). Weight loss of more than 5% in the first 3 months after diagnosis was related to increased occurrence of febrile neutropenic episodes with bacteremia in the first year after diagnosis (odds ratio (OR) = 3.05, 95 % CI = 1.27-7.30, p = 0.012). CONCLUSION: We found that malnourishment in the initial phase of therapy is associated with worse survival in childhood cancer patients. In addition, we found for the first time that weight loss during treatment is associated with increased presence of febrile neutropenic episodes with bacteremia. This underlines the importance of optimal feeding designs in childhood cancer patients.
PURPOSE: In childhood cancerpatients, malnutrition has been proposed to increase infection rates and reduce survival. We investigated whether malnutrition at diagnosis and during treatment and weight loss during treatment are prognostic factors for infection rates and survival, within a heterogeneous childhood cancer population. METHODS: From two previous studies, all children ≤18 years of age diagnosed with cancer between October 2004 and October 2011 were included in this study. Data regarding BMI, infections, and survival were retrieved. Patients with a BMI z-score lower than -2.0 were classified as malnourished. Weight loss more than 5% was considered relevant. RESULTS: Two hundred sixty-nine childhood cancerpatients were included in this study. At diagnosis, 5.2% of all patients were malnourished. These patients showed worse survival than those who were well nourished (hazard ratio (HR) = 3.63, 95% confidence interval (CI) = 1.52-8.70, p = 0.004). Malnourishment at 3 months after diagnosis (3.3% of all patients) also showed worse survival (HR = 6.34, 95% CI = 2.42-16.65, p < 0.001). Weight loss of more than 5% in the first 3 months after diagnosis was related to increased occurrence of febrile neutropenic episodes with bacteremia in the first year after diagnosis (odds ratio (OR) = 3.05, 95 % CI = 1.27-7.30, p = 0.012). CONCLUSION: We found that malnourishment in the initial phase of therapy is associated with worse survival in childhood cancerpatients. In addition, we found for the first time that weight loss during treatment is associated with increased presence of febrile neutropenic episodes with bacteremia. This underlines the importance of optimal feeding designs in childhood cancerpatients.
Authors: Hiroto Inaba; Harriet C Surprise; Stanley Pounds; Xueyuan Cao; Scott C Howard; Karen Ringwald-Smith; Jassada Buaboonnam; Gary Dahl; W Paul Bowman; Jeffrey W Taub; Dario Campana; Ching-Hon Pui; Raul C Ribeiro; Jeffrey E Rubnitz Journal: Cancer Date: 2012-05-30 Impact factor: 6.860
Authors: Anne E Kazak; Matthew C Hocking; Richard F Ittenbach; Anna T Meadows; Wendy Hobbie; Branlyn Werba DeRosa; Ann Leahey; Leslie Kersun; Anne Reilly Journal: Pediatr Blood Cancer Date: 2011-08-19 Impact factor: 3.167
Authors: David Blum; Aurelius Omlin; Vickie E Baracos; Tora S Solheim; Benjamin H L Tan; Patrick Stone; Stein Kaasa; Ken Fearon; Florian Strasser Journal: Crit Rev Oncol Hematol Date: 2011-01-08 Impact factor: 6.312
Authors: Megan E Burke; Elizabeth R Lyden; Jane L Meza; Elena J Ladas; Roshni Dasgupta; Ellen A Wiegner; Carola A S Arndt Journal: Pediatr Blood Cancer Date: 2013-01-17 Impact factor: 3.167
Authors: Aeltsje Brinksma; Robbert Sanderman; Petrie F Roodbol; Esther Sulkers; Johannes G M Burgerhof; Eveline S J M de Bont; Wim J E Tissing Journal: Support Care Cancer Date: 2015-03-10 Impact factor: 3.603
Authors: Mirjam van den Brink; Irene IJpma; Britt van Belkom; Marta Fiocco; Remco C Havermans; Wim J E Tissing Journal: Support Care Cancer Date: 2020-08-02 Impact factor: 3.603